Fundz

Who to call at Onward Therapeutics SA, and when

Fundz watches for the moments Onward Therapeutics SA starts buying, and tells you who to reach.

  • An alert the day Onward Therapeutics SA raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Onward Therapeutics SA, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Onward Therapeutics SA. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Onward Therapeutics Enters Worldwide License Agreement with Institut du Cancer de Montpellier for Onco-Metabolism Program.

Oct 28, 2025

Contract Type

agreement

VaudBiotechnologyHealth CareMedicalTherapeuticsresearch

Description

Onward Therapeutics has exercised its exclusive option to enter a worldwide license agreement with Institut du Cancer de Montpellier to advance its onco-metabolism program. This license agreement follows an earlier collaboration aimed at discovering promising compounds for cancer treatment.

Quick answer

Onward Therapeutics Enters Worldwide License Agreement with Institut du Cancer de Montpellier for Onco-Metabolism Program. (October 28, 2025). Onward Therapeutics SA is based in Vaud, Switzerland.

What agreement did Onward Therapeutics SA announce on October 28, 2025?
Onward Therapeutics has exercised its exclusive option to enter a worldwide license agreement with Institut du Cancer de Montpellier to advance its onco-metabolism program. This license agreement follows an earlier collaboration aimed at discovering promising compounds for cancer treatment.
What does Onward Therapeutics SA do?
Onward Therapeutics SA is a clinical stage oncology company focused on developing innovative therapies for cancer treatment.
Where is Onward Therapeutics SA based?
Onward Therapeutics SA is based in Vaud, Switzerland.

Source: Fundz verified event record.

Company Information

Company

Onward Therapeutics SA

Location

4 Route de la Corniche

Vaud, Switzerland

About

Onward Therapeutics SA is a clinical stage oncology company focused on developing innovative therapies for cancer treatment. With a commitment to advancing onco-metabolism programs, they aim to identify and develop promising compounds for effective cancer care. The company's research efforts are geared towards translating scientific discoveries into breakthrough therapeutic solutions.

Predictive Intelligence
Strategic

ML-powered predictions for Onward Therapeutics SA's next move

Learn about Strategic plan

Onward Therapeutics SA signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.